(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBENZYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBENZYLCYCLOPROPANECARBOXAMIDE](/api/compound/2yEyeAvPHu8.png?ph=true&h=300&w=458 "(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBENZYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | 2yEyeAvPHu8 |
|---|---|
| InChI | InChI=1S/C27H28N4O/c1-2-25(29-30-28)24-18-27(24,23-16-10-5-11-17-23)26(32)31(19-21-12-6-3-7-13-21)20-22-14-8-4-9-15-22/h3-17,24-25H,2,18-20H2,1H3/t24-,25-,27+/m0/s1 |
| InChIKey | HHTFJKHVLOUEMT-OHSXHVKISA-N |
| Mol Weight | 424.55 g/mol |
| Molecular Formula | C27H28N4O |
| Exact Mass | 424.226312 g/mol |
| Enantiomer InChIKey | HHTFJKHVLOUEMT-SLQPCKNISA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
4-(2-chloroethyl)-3-cyclohexyl-1-isopropyl-3-phenyl-2-pyrrolidinone
4-(2-chloroethyl)-3-cyclopentyl-1-isopropyl-3-phenyl-2-pyrrolidinone
SALICYLIC ACID, ESTER WITH 3,3-DIPHENYL-4-(2-HYDROXYETHYL)-1-ISOPROPYL-2-PYRROLIDINONE
1-[3,3-diphenyl-2-methyl-4-oxo-4-(1-pyrrolidinyl)butyl]-4-(alpha,alpha,alpha-trifluoro-m-tolyl)-4-piperidinol, monohydrochloride, dihydrate
NICOTINIC ACID, ESTER WITH 3,3-DIPHENYL-4-(2-HYDROXETHYL)-1-ISOPROPYL-2-PYRROLIDINONE
1,1'-(2,3-Diphenylbutane-1,4-diyl)bis[3-ethyl-3-(4'-chlorphenyl)-1H-pyrrol-2(3H)-one]
2'-methyl-2',3'-dihydro-1'H-spiro[cyclohexane-1,4'-isoquinolin]-2-one
2,5-dioxo-4-phenyl-4-propyl-1-imidazolidineacetic acid, ethyl ester
1,1'-(2,3-Diphenylbutane-1,4-diyl)bis(3-ethyl-3-phenyl-1H-pyrrol-2(3H)-one)
4-(4-CHLORO-alpha,alpha,alpha-TRIFLUORO-m-TOLYL)-alpha,alpha-DIPHENYL-4-HYDROXY-N,N,beta-TRIMETHYL-1-PIPERIDINEBUTYRAMIDE, MONOHYDROCHLORIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) Derivatives Modified at the Carbamoyl Moiety As a New Class of NMDA Receptor Antagonists | Bioorganic & Medicinal Chemistry | 2002 |